Participant Recruitment From Low- and Middle-Income Countries for Pivotal Trials of Drugs Approved by the U.S. Food and Drug Administration-Reference-Cited by-同舟云学术

Participant Recruitment From Low- and Middle-Income Countries for Pivotal Trials of Drugs Approved by the U.S. Food and Drug Administration

Published:2022-12 Issue:12 Volume:175 Page:1675-1684
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Awan Fareed A.¹^ORCID,Becker Andrew B.²,Wang Yuetong¹,Kimmelman Jonathan¹^ORCID

Affiliation:

1. Studies of Translation, Ethics and Medicine, Department of Equity, Ethics and Policy, McGill University, Montreal, Quebec, Canada (F.A.A., Y.W., J.K.)

2. Division of Biostatistics, University of Minnesota, Minneapolis, Minnesota (A.B.B.).

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference45 articles.

1. Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data

2. Haeussler C, Rake B. The changing geography of clinical research: a critical analysis of its drivers. Industrial and Corporate Change. 2017;26:285-310. doi:10.1093/icc/dtx002

3. Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 2015–2016

4. Ethical and Scientific Implications of the Globalization of Clinical Research

5. Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011–2013

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Globalization of clinical research in oncology: Status, challenges, and future directions;Journal of Cancer Policy;2024-12

2. Addressing the gaps in evaluation of new drugs for older adults: Strategies from the International Union of Basic and Clinical Pharmacology (IUPHAR) Geriatric Committee;Journal of the American Geriatrics Society;2024-03-14

3. Geography of authorship: How geography shapes authorship attribution in big team science;Research Policy;2024-03

4. Use of suboptimal control arms in randomized clinical trials of investigational cancer drugs in China, 2016–2021: An observational study;PLOS Medicine;2023-12-12

5. Comparison of safety outcomes of anticancer drugs in Japanese and non-Japanese patients in multi-regional clinical trials: meta-analysis of safety profiles;Investigational New Drugs;2023-05-10